Amyrase
A trademarked form of White Kidney Bean Extract
Amyrase is VitaActives' white kidney bean extract standardised to 8,000 alpha-amylase inhibiting units per gram. No brand-specific clinical trials are indexed yet; evidence shown relates to the parent ingredient.
Manufacturer
VitaActives
Clinical Studies
0
Certifications
0
Purity
8,000 alpha-amylase inhibiting units/g
Last reviewed: 2026-10-06
What Makes It Different
Activity-standardised alpha-amylase inhibitor (8,000 AI units/g) for starch-blocking formulas.
Technical Specifications
Ingredient Type
White kidney bean (Phaseolus vulgaris) extract
Purity / Standardisation
8,000 alpha-amylase inhibiting units/g
Brand Owner
VitaActives
Country of Origin
United Kingdom
Frequently Asked Questions
What is Amyrase?
Amyrase is a trademarked form of White Kidney Bean Extract manufactured by VitaActives. Amyrase is VitaActives' white kidney bean extract standardised to 8,000 alpha-amylase inhibiting units per gram. No brand-specific clinical trials are indexed yet; evidence shown relates to the parent ingredient.
How is Amyrase different from generic White Kidney Bean Extract?
Activity-standardised alpha-amylase inhibitor (8,000 AI units/g) for starch-blocking formulas.
Who makes Amyrase?
Amyrase is made by VitaActives (United Kingdom).
How much clinical evidence does Amyrase have?
SuppIndex lists 0 clinical studies for Amyrase. The parent ingredient White Kidney Bean Extract has an overall evidence score of 35/100 (Limited).
Parent Ingredient
White Kidney Bean Extract
The extract contains phaseolamin, a glycoprotein that inhibits salivary and pancreatic alpha-amylase. Human trials show modest reductions in starch absorption and small weight effects of uncertain clinical significance.
View the parent ingredient page for full evidence review, dosage guidance, mechanism of action, and safety information.
Manufacturer
VitaActives
United Kingdom
Visit WebsiteCompare
See how Amyrase compares to other forms or the generic version.
Open Comparison